US Patent 10195234 Bacteria engineered to reduce hyperphenylalaninemia
Patent 10195234 was granted and assigned to Synlogic on February, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+185 characters)
Article
Patent abstract
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating diseases associated with hyperphenylalaninemia are disclosed.
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Dean Falb0
Jonathan W. Kotula0
Paul F. Miller0
Sarah Rowe0
Vincent M. Isabella0
Yves Millet0
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Apr, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
101952340
Date of Patent
February 5, 2019
0Patent Application Number
153013240
Date Filed
May 13, 2016
0Patent Primary Examiner
Edits on 24 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10195234 Bacteria engineered to reduce hyperphenylalaninemia
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10195234
Date of patent
February 5, 2019
Patent application number
15301324
Date Filed
May 13, 2016
Patent primary examiner
Find more entities like US Patent 10195234 Bacteria engineered to reduce hyperphenylalaninemia
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.